Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kyle T. Greenway, Nicolas Garel, Lisa Jerome & Allison A. Feduccia. (2020) Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology 13:6, pages 655-670.
Read now
Read now
Articles from other publishers (17)
Michael Kelson, Justin M Burnett, Amy Matthews & Tony Juneja. (2023) Ketamine Treatment for Alcohol Use Disorder: A Systematic Review. Cureus.
Crossref
Crossref
Charlotte E. Goldfine, Jeremiah J. Tom, Dana D. Im, Benjamin Yudkoff, Amit Anand, Joseph J. Taylor, Peter R. Chai & Joji Suzuki. (2023) The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review. Frontiers in Psychiatry 14.
Crossref
Crossref
Nicolas Garel, Christina McAnulty, Kyle T. Greenway, Paul Lesperance, Jean-Philippe Miron, Soham Rej, Stephane Richard-Devantoy & Didier Jutras-Aswad. (2022) Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.. Drug and Alcohol Dependence 239, pages 109606.
Crossref
Crossref
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes & Renato Filev. (2022) Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research. Addiction Neuroscience 3, pages 100025.
Crossref
Crossref
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, Kim P. C. Kuypers & Carmela Mento. (2022) Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions. Frontiers in Psychology 13.
Crossref
Crossref
David S. Mathai, Victoria Mora & Albert Garcia-Romeu. (2022) Toward Synergies of Ketamine and Psychotherapy. Frontiers in Psychology 13.
Crossref
Crossref
Igor D. Bandeira, Daniel H. Lins-Silva, Vitor Breseghello Cavenaghi, Ingrid Dorea-Bandeira, Daniela Faria-Guimarães, Judah L. Barouh, Ana Paula Jesus-Nunes, Graziele Beanes, Lucca S. Souza, Gustavo C. Leal, Gerard Sanacora, Euripedes C. Miguel, Aline S. Sampaio & Lucas C. Quarantini. (2022) Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review. Harvard Review of Psychiatry 30:2, pages 135-145.
Crossref
Crossref
Zach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, Shannon Golsof, Johanna Keeler, Beth Marsh, David J. Nutt & Celia J. A. Morgan. (2021) Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open 8:1.
Crossref
Crossref
O. Merve Mollaahmetoglu, Johanna Keeler, Katherine J. Ashbullby, Eirini Ketzitzidou-Argyri, Meryem Grabski & Celia J. A. Morgan. (2021) “This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders. Frontiers in Psychiatry 12.
Crossref
Crossref
Jessica Lochtenberg, Ari Kirshenbaum & Matthew W. Johnson. (2021) Pharmacological assistance for psychotherapy. Emerging Trends in Drugs, Addictions, and Health 1, pages 100017.
Crossref
Crossref
Greer McKendrick, Hannah Garrett, Holly E. Jones, Dillon S. McDevitt, Sonakshi Sharma, Yuval Silberman & Nicholas M. Graziane. (2020) Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice. Frontiers in Behavioral Neuroscience 14.
Crossref
Crossref
Ravi K. Das, Grace Gale, Katie Walsh, Vanessa E. Hennessy, Georges Iskandar, Luke A. Mordecai, Brigitta Brandner, Merel Kindt, H. Valerie Curran & Sunjeev K. Kamboj. (2019) Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nature Communications 10:1.
Crossref
Crossref
Christoph Kraus, Daniel Wasserman, Ioline D. Henter, Elia Acevedo-Diaz, Bashkim Kadriu & Carlos A. ZarateJr.Jr.. (2019) The influence of ketamine on drug discovery in depression. Drug Discovery Today 24:10, pages 2033-2043.
Crossref
Crossref
I. Ivan Ezquerra-Romano, W. Lawn, E. Krupitsky & C.J.A. Morgan. (2018) Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology 142, pages 72-82.
Crossref
Crossref
Peter Eischens & William Leigh Atherton. (2018) Psychedelic therapy as a complementary treatment approach for alcohol use disorders. Journal of Psychedelic Studies 2:1, pages 36-44.
Crossref
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Crossref
Michael P. Bogenschutz & Jessica M. Pommy. (2012) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. Drug Testing and Analysis 4:7-8, pages 543-555.
Crossref
Crossref